|
Segment Information (Details) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2014
|
Jun. 30, 2013
|
|
| Segment Reporting Information | ||||
| Net Sales to External Customers | $ 5,551 | $ 5,446 | $ 10,795 | $ 10,824 |
| Operating Earnings | 737 | 601 | 1,160 | 1,155 |
|
Other
|
||||
| Segment Reporting Information | ||||
| Net Sales to External Customers | 650 | 638 | 1,257 | 1,255 |
|
Total Reportable Segments
|
||||
| Segment Reporting Information | ||||
| Net Sales to External Customers | 4,901 | 4,808 | 9,538 | 9,569 |
| Operating Earnings | 1,129 | 1,034 | 2,085 | 2,109 |
|
Total Reportable Segments | Established Pharmaceutical Products
|
||||
| Segment Reporting Information | ||||
| Net Sales to External Customers | 1,216 | 1,218 | 2,367 | 2,450 |
| Operating Earnings | 245 | 258 | 475 | 543 |
|
Total Reportable Segments | Nutritional Products
|
||||
| Segment Reporting Information | ||||
| Net Sales to External Customers | 1,731 | 1,704 | 3,362 | 3,404 |
| Operating Earnings | 302 | 313 | 585 | 655 |
|
Total Reportable Segments | Diagnostic Products
|
||||
| Segment Reporting Information | ||||
| Net Sales to External Customers | 1,189 | 1,135 | 2,306 | 2,223 |
| Operating Earnings | 279 | 242 | 501 | 503 |
|
Total Reportable Segments | Vascular Products
|
||||
| Segment Reporting Information | ||||
| Net Sales to External Customers | 765 | 751 | 1,503 | 1,492 |
| Operating Earnings | $ 303 | $ 221 | $ 524 | $ 408 |